Showing 1 - 10 of 319
We analyze prescription behavior of physicians in the public and private sector. We study two major diseases for which … private sector physicians are more likely to prescribe the expensive medication. The result holds after controlling for … our cases, we further find that the same physicians prescribe different medication when working in different sectors …
Persistent link: https://www.econbiz.de/10013482204
condition for designing effective policies is to identify who drives antibiotic treatment decisions, physicians or patient …
Persistent link: https://www.econbiz.de/10012599029
national insurance. -- pharmaceuticals ; discrete choice model ; funding-schemes …
Persistent link: https://www.econbiz.de/10009377790
Competition among physicians is widespread, but compelling empirical evidence on the impact on service provision is …
Persistent link: https://www.econbiz.de/10011734380
Policy makers use reference pricing to curb pharmaceutical expenditures by reducing coverage of expensive branded drugs. In a theoretical analysis we show that the net effect of reference pricing is generally ambiguous when accounting for entry by generic producers. Reference pricing shifts...
Persistent link: https://www.econbiz.de/10013285854
We examine the strategic interaction in the market for physician services when the total budget for reimbursement is fixed. We show that this prospective payment system involves { compared to a fee-for-service remuneration system { a severe coordination problem, which potentially leads to the...
Persistent link: https://www.econbiz.de/10011398025
Incentive contracts for gatekeepers who control patient access to specialist medical services provide too weak incentives to investigate cost further when expected cost of treatment is greater than benefit. Making gatekeepers residual claimants with a fixed fee from which treat-ment costs must...
Persistent link: https://www.econbiz.de/10011511048
generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than …. -- pharmaceuticals ; pharmacies ; generic substitution …
Persistent link: https://www.econbiz.de/10009691207
-savings, and that patients' copayments decrease despite the extra surcharges under RP. -- pharmaceuticals ; regulation ; generic …
Persistent link: https://www.econbiz.de/10008749029
curtail the proliferation of prescription opioids. Physicians respond to monitoring on the extensive margin, limiting the …
Persistent link: https://www.econbiz.de/10013177127